Login / Signup

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.

Sue A BrownRoy W BeckDan RaghinaruBruce A BuckinghamLori M B LaffelR Paul WadwaYogish C KudvaCarol J LevyJordan E PinskerEyal DassauFrancis J Doyle IiiLouise Ambler-OsbornStacey M AndersonMei Mei ChurchLaya EkhlaspourGregory P ForlenzaCamilla LevisterVinaya SimhaMarc D BretonCraig KollmanJohn W LumBoris P Kovatchevnull null
Published in: Diabetes care (2020)
Following 6 months of CLC, switching to PLGS reduced TIR and increased HbA1c toward their pre-CLC values, while hypoglycemia remained similarly reduced with both CLC and PLGS.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • metabolic syndrome